TNSN96109A1 - Formes zwitterioniques de trovafloxacine, procede pour leur preparation et compositions les contenant - Google Patents

Formes zwitterioniques de trovafloxacine, procede pour leur preparation et compositions les contenant

Info

Publication number
TNSN96109A1
TNSN96109A1 TNTNSN96109A TNSN96109A TNSN96109A1 TN SN96109 A1 TNSN96109 A1 TN SN96109A1 TN TNSN96109 A TNTNSN96109 A TN TNSN96109A TN SN96109 A TNSN96109 A TN SN96109A TN SN96109 A1 TNSN96109 A1 TN SN96109A1
Authority
TN
Tunisia
Prior art keywords
trovafloxacin
preparation
compositions containing
zwitterionic forms
crystalline
Prior art date
Application number
TNTNSN96109A
Other languages
English (en)
French (fr)
Inventor
John Meldrum Allen Douglas
Bruning Joseph David
Norris Timothy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN96109A1 publication Critical patent/TNSN96109A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TNTNSN96109A 1995-08-29 1996-08-28 Formes zwitterioniques de trovafloxacine, procede pour leur preparation et compositions les contenant TNSN96109A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
TNSN96109A1 true TNSN96109A1 (fr) 2005-03-15

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96109A TNSN96109A1 (fr) 1995-08-29 1996-08-28 Formes zwitterioniques de trovafloxacine, procede pour leur preparation et compositions les contenant

Country Status (30)

Country Link
EP (1) EP0850060A1 (es)
JP (1) JP3188476B2 (es)
KR (1) KR100343909B1 (es)
CN (1) CN1190889A (es)
AP (1) AP636A (es)
AR (1) AR003985A1 (es)
AU (1) AU704115B2 (es)
BR (1) BR9609998A (es)
CA (1) CA2229786C (es)
CO (1) CO4480739A1 (es)
CZ (1) CZ56698A3 (es)
DZ (1) DZ2087A1 (es)
GT (1) GT199600072A (es)
HR (1) HRP960395B1 (es)
HU (1) HUP9900170A3 (es)
IL (1) IL122651A (es)
MA (1) MA23966A1 (es)
MY (1) MY113874A (es)
NO (1) NO309814B1 (es)
NZ (1) NZ312199A (es)
OA (1) OA10669A (es)
PE (1) PE12598A1 (es)
PL (1) PL325170A1 (es)
RU (1) RU2144921C1 (es)
SK (1) SK23898A3 (es)
TN (1) TNSN96109A1 (es)
TR (1) TR199800339T1 (es)
WO (1) WO1997007800A1 (es)
YU (1) YU48396A (es)
ZA (1) ZA967282B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
OA10669A (en) 2000-11-06
HUP9900170A3 (en) 1999-11-29
AR003985A1 (es) 1998-09-30
JP3188476B2 (ja) 2001-07-16
AP9600853A0 (en) 1996-10-31
KR19990044232A (ko) 1999-06-25
CN1190889A (zh) 1998-08-19
AU704115B2 (en) 1999-04-15
WO1997007800A1 (en) 1997-03-06
ZA967282B (en) 1998-03-02
YU48396A (sh) 1998-12-23
CO4480739A1 (es) 1997-07-09
AU6367696A (en) 1997-03-19
SK23898A3 (en) 1999-05-07
PL325170A1 (en) 1998-07-06
IL122651A0 (en) 1998-08-16
MY113874A (en) 2002-06-29
MA23966A1 (fr) 1997-04-01
NO309814B1 (no) 2001-04-02
AP636A (en) 1998-04-09
CA2229786A1 (en) 1997-03-06
HRP960395B1 (en) 2001-12-31
KR100343909B1 (ko) 2003-04-10
BR9609998A (pt) 1999-07-06
CZ56698A3 (cs) 1999-02-17
GT199600072A (es) 1998-02-14
IL122651A (en) 2000-02-17
CA2229786C (en) 2002-02-19
HRP960395A2 (en) 1998-06-30
NZ312199A (en) 1999-06-29
TR199800339T1 (xx) 1998-06-22
MX9801664A (es) 1998-08-30
DZ2087A1 (fr) 2002-07-22
NO980862D0 (no) 1998-02-27
JPH10511692A (ja) 1998-11-10
EP0850060A1 (en) 1998-07-01
PE12598A1 (es) 1998-03-20
RU2144921C1 (ru) 2000-01-27
HUP9900170A2 (hu) 1999-05-28
NO980862L (no) 1998-02-27

Similar Documents

Publication Publication Date Title
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98150A1 (fr) Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98182A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99073A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
TNSN98022A1 (fr) DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98112A1 (fr) Composes dipeptidiques
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98238A1 (fr) Macrolides nouveaux
TNSN99039A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN96172A1 (fr) Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99170A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN01017A1 (fr) Compositions comprenant un antibiotique azalide, et procedes pour leur preparation
TNSN99169A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98066A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
TNSN01167A1 (fr) Formes de sels d'amide d'acide 3-(4-bromo-2,6-difluoro-benzyloxy) - 5 [3 - (4 - pyrrolidine - 1 - yl - butyl) ureido] isothiazole - 4 - carboxylique, et procede pour leur production.
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.